Higher urinary thallium concentration showed a nominal positive association with cardiovascular mortality in the original scale, but this association was not robust to natural-log transformation, and single-cell transcriptomic analyses identified candidate genes in vascular smooth muscle cells and macrophages that are hypothesis-generating only.
Key Findings
Results
Urinary thallium concentration showed a nominal positive association with cardiovascular mortality in the fully adjusted original-scale analysis.
OR = 2.13, 95% CI: 1.21–3.75; unadjusted P = 0.011
This was described as a 'nominal positive association' in the original scale
The analysis used NHANES data in a cross-sectional design
P values in multi-metal screening analyses were not adjusted for multiple comparisons
Results
The association between urinary thallium and cardiovascular mortality was not statistically significant after natural-log transformation of urinary thallium.
OR = 1.53, 95% CI: 0.71–3.28; P = 0.264 after natural-log transformation
The authors explicitly stated the association was 'not robust to natural-log transformation'
This lack of robustness to a standard epidemiological transformation undermines confidence in the original-scale finding
The study characterized the overall cross-sectional analysis as exploratory
Results
Exploratory analyses of public disease-context single-cell transcriptomic datasets identified expression patterns of database-derived thallium-related candidate genes across vascular smooth muscle cells (VSMCs), macrophages, and other cell types.
Candidate gene expression patterns were identified in VSMCs, macrophages, and other cell types
These candidate genes overlapped with disease-associated transcriptional programs annotated to VSMC phenotypic state and lipid metabolism
The datasets used did not include donor-level thallium measurements
The authors explicitly stated these observations 'were used only to nominate hypotheses for future studies and were not interpreted as evidence of thallium-induced cellular changes or regulatory pathways'
Discussion
The transcriptomic findings are hypothesis-generating and do not establish that thallium exposure directly caused the observed cellular changes or activated specific regulatory pathways.
Neither single-cell dataset included donor-level thallium measurements
Candidate genes were 'database-derived thallium-related candidate genes,' not genes measured in thallium-exposed individuals
The authors stated these findings 'require validation in studies with repeated exposure assessment and experimental models'
The paper explicitly warned these results 'should be interpreted as preliminary and not as evidence of a causal relationship'
Conclusions
The study was characterized as an exploratory cross-sectional analysis with multiple methodological limitations precluding causal inference.
Cross-sectional design was used, limiting causal interpretation
Urinary thallium was measured as a single time-point, without repeated exposure assessment
Multi-metal screening analyses were exploratory and P values were not adjusted for multiple comparisons
The authors recommended future studies incorporate 'repeated exposure assessment and experimental models'
What This Means
This research examined whether higher levels of thallium — a toxic heavy metal found in the environment — in people's urine were linked to dying from cardiovascular (heart and blood vessel) disease. Using data from NHANES, a large U.S. health survey, the researchers found a statistically significant association when thallium was measured on its original scale, but this association disappeared when thallium levels were mathematically transformed in a standard way (using a natural logarithm). This inconsistency means the finding is not reliable, and the authors themselves described the results as preliminary and exploratory rather than as evidence of a real causal link.
The study also analyzed publicly available single-cell genetic datasets from diseased blood vessels to look for genes that might connect thallium exposure to heart disease. They identified some candidate genes expressed in vascular smooth muscle cells and immune cells (macrophages) that overlapped with processes like lipid metabolism and changes in cell behavior. However, these datasets did not include any actual measurements of thallium in the donors, so the researchers were careful to say these observations only suggest ideas for future experiments — they do not prove that thallium causes these cellular changes.
This research suggests that environmental thallium exposure warrants further investigation as a potential cardiovascular risk factor, but the current evidence is too weak and inconsistent to draw firm conclusions. The study's cross-sectional design (a snapshot in time), single urine measurement per person, and statistically fragile findings all point to the need for stronger studies with repeated exposure measurements, longer follow-up periods, and laboratory experiments before any conclusions about thallium and heart disease risk can be made.
Lei Y, Xia L, Xu M, Huang N, Jiang Q. (2026). Urinary Thallium Concentration and Cardiovascular Mortality: An Exploratory NHANES Analysis with Disease-Context Single-Cell Transcriptomic Hypothesis Generation.. Cardiovascular toxicology. https://doi.org/10.1007/s12012-026-10205-9